
Equal-WT
WhaleScore 2.0
?
2025-09-30
| Name | % Change |
|---|---|
| BBOT BridgeBio Oncology T | 1.46% |
| CRNX Crinetics Pharmaceut | 1.22% |
| PHVS Pharvaris NV | 0.67% |
| ELVN Enliven Therapeutics | 0.35% |
| APGE Apogee Therapeutics | -0.1% |
2025-09-30
| Name | % Change |
|---|---|
| INSM Insmed Inc | 2.97% |
| BPMC Blueprint Medicines | 2.4% |
| CBLL Ceribell Inc | 1.19% |
| RXRX Recursion Pharmaceut | 0.96% |
| ASML ASML Holding NV | 0.28% |
2025-09-30
| Name | % of Portfolio |
|---|---|
| VTI Vanguard Total Stock | 21.97% |
| BN Brookfield Corporati | 10.3% |
| ASML ASML Holding NV | 9.1% |
| MIRM Mirum Pharmaceutical | 5.97% |
| EWTX Edgewise Therapeutic | 5.59% |
2025-09-30
| Market Value | $1.55b, Prior: $1.42b |
| Inflows (Outflows) as % of Total MV | (-10.4692)% |
| New Purchases | 1 stocks |
| Added To | 5 stocks |
| Sold out of | 3 stocks |
| Reduced holdings in | 10 stocks |
| Top 10 Holdings % | 73.16% |
| Turnover %[1] | 13.33% |
| Turnover Alt %[2] | 2.37% |
| Time Held Top 20 | 8.05 quarters |
| Time Held Top 10 | 5.5 quarters |
| Time Held All | 10.96 quarters |
[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.
2025-09-30
2025-09-30
Top 20 equal-weighted holdings. Performance numbers calculated through 2025-09-30